Funds · 13F holdings

Andera Partners

13F holdings for Q2 2026 · PARIS, I0 · filed July 22, 2026

Andera Partners reported $206M in 13F securities across 8 holdings for Q2 2026, in a Form 13F filed July 22, 2026. The largest positions were Kestra Med Technologies LTD (33.6%), MLYS (20.8%), AVLN (14.8%). Reported value rose 16.7% from the quarter before. It opened 1 new position, added to 2, trimmed 1 and sold out of 0.

13F value Q2 2026
$206M
Holdings
8
Change vs prior quarter
+16.7%
Rank by 13F value
#6,434

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Top holdings

StockValueWeightSharesChange in sharesMove
Kestra Med Technologies LTD$69.4M33.6%2,728,679+1.2%Added
MLYS Mineralys Therapeutics Inc.$42.9M20.8%1,591,9170%Unchanged
AVLN Avalyn Pharma Inc.$30.6M14.8%929,824NewNew
AGMB AgomAb Therapeutics NV$20.0M9.7%1,538,7020%Unchanged
EVMN Evommune Inc.$18.5M9.0%1,391,990-26.6%Trimmed
IVA Inventiva S.A.$13.7M6.7%3,633,181+99.8%Added
ABVX Abivax SA$10.4M5.0%78,1250%Unchanged
Nyxoah S A$882K0.4%522,0570%Unchanged

Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $206M in share positions; options and bonds count in the 13F value but not here.

Biggest buys in Q2 2026

  1. AVLN Avalyn Pharma Inc. New+$30.6M
  2. IVA Inventiva S.A. Added+$6.9M
  3. Kestra Med Technologies LTD Added+$852K

Biggest sells in Q2 2026

  1. EVMN Evommune Inc. Trimmed-$6.7M

The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 1 new, 2 added, 1 trimmed, 0 sold out.

Sector mix

13F value by quarter

Q4 '25
Q1 '26
Q2 '26
Reported 13F value: Q4 2025 $177M, Q1 2026 $177M, Q2 2026 $206M.

Schedule 13D and 13G filings by Andera Partners

Stakes above 5% of a company, filed within days rather than once a quarter.

Questions about Andera Partners

What does Andera Partners own?
In its Form 13F for Q2 2026, Andera Partners reported 8 holdings worth $206M. The five largest were Kestra Med Technologies LTD, MLYS, AVLN, AGMB, EVMN.
What did Andera Partners buy and sell in Q2 2026?
Andera Partners opened 1 new position, added to 2, trimmed 1 and sold out of 0 compared with the quarter before.
When did Andera Partners file its latest 13F?
Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed July 22, 2026.

From Form 13F filed by Andera Partners (SEC CIK 0001757283) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds